Skip to main content
. 2012 Aug 6;7(8):e42609. doi: 10.1371/journal.pone.0042609

Figure 7. HCV Genome Replication Inhibitors.

Figure 7

A. The genome replication inhibitors (Inhs 6–13) were confirmed by comparing potency (EC50) against the 1a/2a-Rluc virus and a corresponding JFH1 replicon. B & C. Genotype 2a and HCV selectivity were assessed by comparing inhibitor potency against genotype 2a, genotype 1a and BVDV replicons and compounds were subsequently grouped into genotype 2a-selective (B) and non-selective (C).